These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7435389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reentrant arrhythmias in the subacute infarction period. The proarrhythmic effect of flecainide acetate on functional reentrant circuits.
    Restivo M, Yin H, Caref EB, Patel AI, Ndrepepa G, Avitable MJ, Assadi MA, Isber N, el-Sherif N.
    Circulation; 1995 Feb 15; 91(4):1236-46. PubMed ID: 7850964
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
    Vogel M, Desoutter P, Bellanger P, Motté G, Welti JJ.
    Arch Mal Coeur Vaiss; 1976 Apr 15; 69(4):395-406. PubMed ID: 59581
    [Abstract] [Full Text] [Related]

  • 8. Cellular electrophysiologic changes induced by disopyramide phosphate in normal infarcted hearts.
    Sasyniuk BI, Kus T.
    J Int Med Res; 1976 Apr 15; 4(1 Suppl):20-5. PubMed ID: 1026524
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
    Katoh H, Ogawa S, Furuno I, Sato Y, Yoh S, Saeki K, Nakamura Y.
    J Pharmacol Exp Ther; 1990 Jun 15; 253(3):1077-82. PubMed ID: 2359016
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
    Lynch JJ, Heaney LA, Wallace AA, Gehret JR, Selnick HG, Stein RB.
    J Cardiovasc Pharmacol; 1990 May 15; 15(5):764-75. PubMed ID: 1692937
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction.
    Patterson E, Gibson JK, Lucchesi BR.
    Pharmacology; 1988 May 15; 36(2):73-83. PubMed ID: 3353442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.